Uncovering the Peptide-Binding Specificities of HLA-C: A General Strategy To Determine the Specificity of Any MHC Class I Molecule

MHC class I molecules (HLA-I in humans) present peptides derived from endogenous proteins to CTLs. Whereas the peptide-binding specificities of HLA-A and -B molecules have been studied extensively, little is known about HLA-C specificities. Combining a positional scanning combinatorial peptide library approach with a peptide–HLA-I dissociation assay, in this study we present a general strategy to determine the peptide-binding specificity of any MHC class I molecule. We applied this novel strategy to 17 of the most common HLA-C molecules, and for 16 of these we successfully generated matrices representing their peptide-binding motifs. The motifs prominently shared a conserved C-terminal primary anchor with hydrophobic amino acid residues, as well as one or more diverse primary and auxiliary anchors at P1, P2, P3, and/or P7. Matrices were used to generate a large panel of HLA-C–specific peptide-binding data and update our pan-specific NetMHCpan predictor, whose predictive performance was considerably improved with respect to peptide binding to HLA-C. The updated predictor was used to assess the specificities of HLA-C molecules, which were found to cover a more limited sequence space than HLA-A and -B molecules. Assessing the functional significance of these new tools, HLA-C*07:01 transgenic mice were immunized with stable HLA-C*07:01 binders; six of six tested stable peptide binders were immunogenic. Finally, we generated HLA-C tetramers and labeled human CD8+ T cells and NK cells. These new resources should support future research on the biology of HLA-C molecules. The data are deposited at the Immune Epitope Database, and the updated NetMHCpan predictor is available at the Center for Biological Sequence Analysis and the Immune Epitope Database.

[1]  O. Lund,et al.  NetMHCpan, a method for MHC class I binding prediction beyond humans , 2008, Immunogenetics.

[2]  S Brunak,et al.  Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach. , 2003, Tissue antigens.

[3]  U. Hobohm,et al.  Selection of representative protein data sets , 1992, Protein science : a publication of the Protein Society.

[4]  O. Mandelboim,et al.  Self and viral peptides can initiate lysis by autologous natural killer cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Don C. Wiley,et al.  Structure of Human Histocompatibility Leukocyte Antigen (Hla)-Cw4, a Ligand for the Kir2d Natural Killer Cell Inhibitory Receptor , 1999, The Journal of experimental medicine.

[6]  H. Rammensee,et al.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.

[7]  Soung Hie Kim,et al.  An Artificial Neural Network Approach , 1993 .

[8]  Morten Nielsen,et al.  Seq2Logo: a method for construction and visualization of amino acid binding motifs and sequence profiles including sequence weighting, pseudo counts and two-sided representation of amino acid enrichment and depletion , 2012, Nucleic Acids Res..

[9]  C. Sylvester-Hvid,et al.  Efficient assembly of recombinant major histocompatibility complex class I molecules with preformed disulfide bonds , 2001, European journal of immunology.

[10]  M. Altfeld,et al.  Mutiny or scrutiny: NK cell modulation of DC function in HIV-1 infection. , 2011, Trends in immunology.

[11]  K. Parker,et al.  Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. , 1994, Journal of immunology.

[12]  Søren Buus,et al.  Real-time, high-throughput measurements of peptide-MHC-I dissociation using a scintillation proximity assay. , 2011, Journal of immunological methods.

[13]  C. Heirman,et al.  Identification of New Antigenic Peptide Presented by HLA-Cw7 and Encoded by Several MAGE Genes Using Dendritic Cells Transduced with Lentiviruses 1 , 2004, The Journal of Immunology.

[14]  Y. Godet,et al.  A HLA-Cw*0701 restricted Melan-A/MART1 epitope presented by melanoma tumor cells to CD8+ tumor infiltrating lymphocytes , 2008, Cancer Immunology, Immunotherapy.

[15]  Morten Nielsen,et al.  NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8–11 , 2008, Nucleic Acids Res..

[16]  K. Collins,et al.  The emerging role of HLA‐C in HIV‐1 infection , 2011, Immunology.

[17]  D. Zipeto,et al.  HLA-C and HIV-1: friends or foes? , 2012, Retrovirology.

[18]  V. Gnau,et al.  Allele-specific peptide ligand motifs of HLA-C molecules. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Carroll,et al.  Identification of a major histocompatibility complex class I‐restricted T‐cell epitope in the tumour‐associated antigen, 5T4 , 2006, Immunology.

[20]  Bjoern Peters,et al.  Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries , 2008, Immunome research.

[21]  D. Lake,et al.  Identification of HLA-Cw6.02 and HLA-Cw7.01 allele-specific binding motifs by screening synthetic peptide libraries , 2004, Immunogenetics.

[22]  P. Parham,et al.  Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules , 2012, Philosophical Transactions of the Royal Society B: Biological Sciences.

[23]  P. Parham,et al.  Review: Immunogenetics of human placentation. , 2012, Placenta.

[24]  Jeffrey C. Boyington,et al.  Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand , 2000, Nature.

[25]  S. Robson,et al.  Review: Functional role of uterine natural killer (uNK) cells in human early pregnancy decidua. , 2010, Placenta.

[26]  C. Sylvester-Hvid,et al.  One-Pot, Mix-and-Read Peptide-MHC Tetramers , 2008, PloS one.

[27]  Søren Buus,et al.  Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificities: quantitation by peptide libraries and improved prediction of binding , 1996, European journal of immunology.

[28]  Morten Nielsen,et al.  The peptide-binding specificity of HLA-A*3001 demonstrates membership of the HLA-A3 supertype , 2008, Immunogenetics.

[29]  H. Sebastian Seung,et al.  Query by committee , 1992, COLT '92.

[30]  S. Buus,et al.  HLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 Monochain Transgenic/H-2 Class I Null Mice: Novel Versatile Preclinical Models of Human T Cell Responses , 2013, The Journal of Immunology.

[31]  M. Nielsen,et al.  Identification and HLA-Tetramer-Validation of Human CD4+ and CD8+ T Cell Responses against HCMV Proteins IE1 and IE2 , 2014, PloS one.

[32]  Morten Nielsen,et al.  Peptide‐MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity , 2012, European journal of immunology.

[33]  Eric O Long,et al.  The Direct Binding of a p58 Killer Cell Inhibitory Receptor to Human Histocompatibility Leukocyte Antigen (HLA)-Cw4 Exhibits Peptide Selectivity , 1997, The Journal of experimental medicine.

[34]  Morten Nielsen,et al.  NetMHCcons: a consensus method for the major histocompatibility complex class I predictions , 2011, Immunogenetics.

[35]  J J Goedert,et al.  Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. , 2001, The New England journal of medicine.

[36]  O. Lund,et al.  NetMHCpan, a Method for Quantitative Predictions of Peptide Binding to Any HLA-A and -B Locus Protein of Known Sequence , 2007, PloS one.

[37]  K. Parker,et al.  Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Nielsen,et al.  Peptide Binding to HLA Class I Molecules: Homogenous, High-Throughput Screening, and Affinity Assays , 2009, Journal of biomolecular screening.

[39]  Clemencia Pinilla,et al.  Derivation of an amino acid similarity matrix for peptide:MHC binding and its application as a Bayesian prior , 2009, BMC Bioinformatics.

[40]  F. Greenwood,et al.  Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity , 1962, Nature.

[41]  C. Sylvester-Hvid,et al.  Purification of correctly oxidized MHC class I heavy‐chain molecules under denaturing conditions: A novel strategy exploiting disulfide assisted protein folding , 2003, Protein science : a publication of the Protein Society.

[42]  B. Walker,et al.  HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes , 1998, Nature.

[43]  Søren Buus,et al.  A novel system for continuous protein refolding and on‐line capture by expanded bed adsorption , 2005, Protein science : a publication of the Protein Society.

[44]  T. Elliott,et al.  Peptide antagonism as a mechanism for NK cell activation , 2010, Proceedings of the National Academy of Sciences.

[45]  P. Parham,et al.  Chimpanzees Use More Varied Receptors and Ligands Than Humans for Inhibitory Killer Cell Ig-Like Receptor Recognition of the MHC-C1 and MHC-C2 Epitopes1 , 2009, The Journal of Immunology.

[46]  O. Lund,et al.  MHCcluster, a method for functional clustering of MHC molecules , 2013, Immunogenetics.